Close

Notable 52-Week Highs and Lows 9/28: (SRPT) (NVDA) (CLD) High; (FGP) (GBSN) Low

September 28, 2016 3:05 PM EDT Send to a Friend
52-Week High:Sarepta Therapeutics (Nasdaq: SRPT) $63.73. Sarepta Therapeutics muscular dystrphy drug Exondys received broad coverage from Cigna. RBC Capital ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login